Comment: Thiazolidinediones in type 2 diabetes: a cardiology perspective

Ann Pharmacother. 2009 Feb;43(2):391-2; author reply 392-3. doi: 10.1345/aph.1K666a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cardiovascular Diseases / chemically induced*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Humans
  • Randomized Controlled Trials as Topic
  • Thiazolidinediones / adverse effects*

Substances

  • Thiazolidinediones